###begin article-title 0
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human DNA polymerase beta polymorphism, Arg137Gln, impairs its polymerase activity and interaction with PCNA and the cellular base excision repair capacity
###end article-title 0
###begin p 1
###xml 817 825 799 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 825 828 804 807 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 964 965 943 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 973 974 952 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 1023 1031 1002 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 1031 1034 1007 1010 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 165 170 <span type="species:ncbi:9606">human</span>
###xml 829 834 <span type="species:ncbi:10090">mouse</span>
DNA polymerase beta (Pol beta) is a key enzyme in DNA base excision repair, and an important factor for maintaining genome integrity and stability. More than 30% of human tumors characterized to date express DNA Pol beta variants, many of which result from a single nucleotide residue substitution. However, in most cases, their precise functional deficiency and relationship to cancer susceptibility are still unknown. In the current work, we show that a polymorphism encoding an arginine to glutamine substitution, R137Q, has lower polymerase activity. The substitution also affects the interaction between Pol beta and proliferating cell nuclear antigen (PCNA). These defects impair the DNA repair capacity of Pol beta in reconstitution assays, as well as in cellular extracts. Expression of wild-type Pol beta in pol beta-/- mouse embryonic fibroblast (MEF) cells restored cellular resistance to DNA damaging reagents such as methyl methanesulfonate (MMS) and N-methyl-N-nitrosourea (MNU), while expression of R137Q in pol beta-/- MEF cells failed to do so. These data indicate that polymorphisms in base excision repair genes may contribute to the onset and development of cancers.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 261 262 261 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 263 264 263 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 372 373 372 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 530 531 530 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 532 533 532 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 598 599 598 599 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 641 644 641 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5 B6 B7">5&#8211;7</xref>
###xml 843 844 843 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 976 977 976 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 978 980 978 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1273 1275 1261 1263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1276 1278 1264 1266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1462 1467 1443 1448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13 B14 B15 B16 B17">13&#8211;17</xref>
###xml 1504 1505 1485 1486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
Genomic DNA is constantly exposed to endogenous and exogenous insults, which react with base and sugar groups causing DNA damage which, if not repaired, may result in genetic mutations, and subsequently contribute to genome instabilities and cancer initiation (1,2). Removal of DNA damage and maintenance of genomic integrity depend on robust cellular DNA repair systems (2). Base excision repair (BER) is one of the major repair pathways in eukaryotic cells, processing DNA base damage caused by endogenous and exogenous agents (3,4). It is estimated that BER is responsible for repairing about 104 damaged/modified bases per cell per day (5-7). BER is initiated with the excision of the damaged base by a specific DNA glycosylase, followed by incision of the DNA backbone by AP endonuclease 1 (APE1) to produce a nicked abasic intermediate (8). This intermediate structure can be processed through either the short-patch BER (SP-BER) or the long-patch BER (LP-BER) pathway (9,10). In the former, DNA polymerase beta (Pol beta) adds only one nucleotide to the 3'-end of the nicked AP site, and then the dRP lyase activity of Pol beta catalyzes beta-elimination of the 5'-sugar phosphate residue, resulting in a ligatable nick that can then be sealed by XRCC1/Ligase IIIa (11,12). In the latter, Pol beta or the alternative Pol delta performs strand displacement synthesis, generating a short DNA flap of 2-10 nt, which is removed by flap endonuclease 1 (FEN1) (13-17). DNA ligase I then seals the nick (9).
###end p 3
###begin p 4
###xml 114 116 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 117 119 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 438 440 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 522 527 513 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21 B22 B23 B24 B25">21&#8211;25</xref>
###xml 573 575 564 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 588 590 579 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 591 593 582 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 948 950 936 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 951 953 939 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 1117 1118 1102 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 1126 1127 1111 1112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 1334 1342 1316 1324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in&#160;vitro</italic>
###xml 1344 1349 1326 1331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30 B31 B32 B33">30&#8211;33</xref>
###xml 980 984 <span type="species:ncbi:10090">mice</span>
Of the tens of BER proteins identified, Pol beta has been demonstrated to be a key player in both SP- and LP-BER (18,19). Pol beta, a 39 kDa protein, contains two domains; a dRP lyase domain (8 kDa) and a polymerase domain (31 kDa). These two domains correspond to the dRP lyase and polymerase activities, which are responsible for the removal of the sugar phosphate group and the incorporation of new deoxyribonucleotides, respectively (20). In addition, Pol beta also interacts with many other proteins including XRCC1 (21-25), proliferating cell nuclear antigen (PCNA) (26), and FEN1 (27,28). These interactions likely play important roles in recruiting downstream factors to the DNA repair site, reciprocally stimulating enzyme activities and coordinating the highly ordered chemical reactions of BER. Pol beta deficiency has been demonstrated to impair BER efficiency and to cause cells to be hypersensitive to alkylating or oxidative agents (15,29). Knockout of Pol beta in mice abolishes BER and causes the mutant cell to be hypersensitive to DNA damaging reagents, including methyl methanesulfonate (MMS) and N-methyl-N-nitrosourea (MNU), leading to early embryonic lethality. Pol beta mutations that affect its dRP lyase, polymerase activity or its interaction with other proteins, have been shown to result in defective BER in vitro (30-33).
###end p 4
###begin p 5
###xml 66 68 66 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 207 212 207 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34 B35 B36 B37">34&#8211;37</xref>
###xml 786 788 774 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 1118 1120 1103 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 458 464 <span type="species:ncbi:9606">humans</span>
###xml 1447 1452 <span type="species:ncbi:10090">mouse</span>
Single nucleotide polymorphisms occur widely in DNA repair genes (34). While previous research suggests polymorphisms may result in biochemical alternations, BER deficiency and predisposition to cancers (31,34-37), it is still of significant interest to determine whether and how a polymorphism increases the susceptibility to development of cancers. For DNA Pol beta, three non-synonymous single nucleotide substitutions were identified as polymorphisms in humans. These are Q8R, R137Q and P242R. However, it is unknown whether the polymorphism affects Pol beta's function and contributes to cancer initiation and development. Among the three DNA Pol beta polymorphisms, R137Q is particularly interesting because the residue at position 137 locates in the helix 7 of Pol beta protein (38) and forms salt bridges with other adjacent amino acid residues. The amino acid substitution of Arg by Gln results in a net positive charge loss and might lead to significant alterations in biochemical and physiological properties of the enzyme. Moreover, a recent report showed that R137 is also a methylation site of Pol beta (39). In the current study, we expressed and purified the R137Q Pol beta variant and found that R137Q significantly reduced polymerase activity. It also showed impaired interaction with PCNA. As a result, the R137Q substitution reduced BER efficiency when assayed in a reconstitution assay or with cellular extracts. Furthermore, mouse cells expressing the R137Q variant accumulated DNA damage lesions in the genome and were sensitive to DNA damaging agents. These results suggest that the R137Q polymorphism affected Pol beta biochemical activity resulting in defective BER, which might subsequently contribute to genome instability and cancer development.
###end p 5
###begin title 6
EXPERIMENTAL PROCEDURES
###end title 6
###begin title 7
Preparation of recombinant wild-type and variant Pol beta
###end title 7
###begin p 8
###xml 25 33 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 165 172 162 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table&#160;1</xref>
###xml 247 263 244 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 335 337 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 340 348 337 345 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table&#160;1.</label>
###xml 348 409 345 406 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="9">Oligonuleotide sequences and their applications in this study</p>
###xml 348 409 345 406 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="9">Oligonuleotide sequences and their applications in this study</p></caption>
###xml 409 409 406 406 <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp201i1.jpg"/>
###xml 409 409 406 406 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><inline-graphic xlink:href="gkp201i1.jpg"/></td>
###xml 409 409 406 406 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"><inline-graphic xlink:href="gkp201i1.jpg"/></td></tr>
###xml 409 409 406 406 <table xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" frame="hsides" rules="groups"><tr><td rowspan="1" colspan="1"><inline-graphic xlink:href="gkp201i1.jpg"/></td></tr></table>
###xml 409 410 406 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 409 429 406 426 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="10"><sup>a</sup>P: phosphate group.</p>
###xml 409 429 406 426 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="TF1"><p textid="10"><sup>a</sup>P: phosphate group.</p></fn>
###xml 429 430 426 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 429 440 426 437 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="11"><sup>b</sup>U: uracil.</p>
###xml 429 440 426 437 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="TF2"><p textid="11"><sup>b</sup>U: uracil.</p></fn>
###xml 440 441 437 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
###xml 440 466 437 463 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="12"><sup>c</sup>F: Tetrahydrofuran (THF).</p>
###xml 440 466 437 463 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="TF3"><p textid="12"><sup>c</sup>F: Tetrahydrofuran (THF).</p></fn>
###xml 409 466 406 463 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><fn id="TF1"><p textid="10"><sup>a</sup>P: phosphate group.</p></fn><fn id="TF2"><p textid="11"><sup>b</sup>U: uracil.</p></fn><fn id="TF3"><p textid="12"><sup>c</sup>F: Tetrahydrofuran (THF).</p></fn></table-wrap-foot>
###xml 340 466 337 463 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T1" position="float"><label>Table&#160;1.</label><caption><p textid="9">Oligonuleotide sequences and their applications in this study</p></caption><table frame="hsides" rules="groups"><tr><td rowspan="1" colspan="1"><inline-graphic xlink:href="gkp201i1.jpg"/></td></tr></table><table-wrap-foot><fn id="TF1"><p textid="10"><sup>a</sup>P: phosphate group.</p></fn><fn id="TF2"><p textid="11"><sup>b</sup>U: uracil.</p></fn><fn id="TF3"><p textid="12"><sup>c</sup>F: Tetrahydrofuran (THF).</p></fn></table-wrap-foot></table-wrap>
###xml 19 24 <span type="species:ncbi:9606">human</span>
###xml 57 62 <span type="species:ncbi:9606">human</span>
###xml 247 275 <span type="species:ncbi:511693">Escherichia coli strain BL21</span>
The wild-type (WT) human pol beta cDNA was cloned from a human cDNA library. R137Q substitution was obtained by site-directed mutagenesis using the primers shown in Table 1. WT and R137Q genes were inserted into the pET28b vector and expressed in Escherichia coli strain BL21. Expressed proteins were purified as previously described (40). Table 1.Oligonuleotide sequences and their applications in this studyaP: phosphate group.bU: uracil.cF: Tetrahydrofuran (THF).
###end p 8
###begin p 9
Oligonuleotide sequences and their applications in this study
###end p 9
###begin p 10
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
aP: phosphate group.
###end p 10
###begin p 11
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
bU: uracil.
###end p 11
###begin p 12
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
cF: Tetrahydrofuran (THF).
###end p 12
###begin title 13
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In&#160;vitro</italic>
In vitro polymerase activity assay
###end title 13
###begin p 14
###xml 74 75 74 75 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 166 173 162 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table&#160;1</xref>
###xml 178 186 174 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure&#160;1</xref>
###xml 271 273 251 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 840 849 805 814 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure&#160;1.</label>
###xml 919 920 881 882 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1125 1127 1085 1087 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1323 1324 1280 1281 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1525 1526 1482 1483 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1632 1634 1586 1588 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1657 1658 1611 1612 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 849 1841 814 1792 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="15">The Pol &#946; polymorphism R137Q is defective in polymerase activity. (<bold>A</bold>) Top panel, schematic of the biotin-labeled 1-nt gapped DNA substrate (Pol-GAP); bottom panel, polymerase activity assay in which Pol-GAP was incubated with 50 &#956;M each of dATP, dGTP, dTTP and 8 &#956;M dCTP-<sup>32</sup>P and varying amounts of purified Pol &#946; protein (WT and R137Q). WT and R137Q DNA polymerization products were separated by denaturing gel electrophoresis and visualized with a phosphorimager. (<bold>B</bold>) DNA polymerization products were pulled down by Sepharose&#8211;avidin beads. After washing, the amount of radio-nucleotide incorporated into the products was determined by liquid scintillation counting. (<bold>C</bold>) Gel shift assay of DNA-binding affinity of R137Q and WT Pol &#946;. In this assay, Pol-GAP was labeled by <sup>32</sup>P as shown in figure. (<bold>D</bold>) ELISA-based isotherm adsorption assay of DNA-binding affinity of R137Q and WT Pol &#946;. The DNA substrate was the same as that used in (A). WT, filled squares; R137, filled circles.</p>
###xml 849 1841 814 1792 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="15">The Pol &#946; polymorphism R137Q is defective in polymerase activity. (<bold>A</bold>) Top panel, schematic of the biotin-labeled 1-nt gapped DNA substrate (Pol-GAP); bottom panel, polymerase activity assay in which Pol-GAP was incubated with 50 &#956;M each of dATP, dGTP, dTTP and 8 &#956;M dCTP-<sup>32</sup>P and varying amounts of purified Pol &#946; protein (WT and R137Q). WT and R137Q DNA polymerization products were separated by denaturing gel electrophoresis and visualized with a phosphorimager. (<bold>B</bold>) DNA polymerization products were pulled down by Sepharose&#8211;avidin beads. After washing, the amount of radio-nucleotide incorporated into the products was determined by liquid scintillation counting. (<bold>C</bold>) Gel shift assay of DNA-binding affinity of R137Q and WT Pol &#946;. In this assay, Pol-GAP was labeled by <sup>32</sup>P as shown in figure. (<bold>D</bold>) ELISA-based isotherm adsorption assay of DNA-binding affinity of R137Q and WT Pol &#946;. The DNA substrate was the same as that used in (A). WT, filled squares; R137, filled circles.</p></caption>
###xml 1841 1841 1792 1792 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp201f1"/>
###xml 840 1841 805 1792 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F1" position="float"><label>Figure&#160;1.</label><caption><p textid="15">The Pol &#946; polymorphism R137Q is defective in polymerase activity. (<bold>A</bold>) Top panel, schematic of the biotin-labeled 1-nt gapped DNA substrate (Pol-GAP); bottom panel, polymerase activity assay in which Pol-GAP was incubated with 50 &#956;M each of dATP, dGTP, dTTP and 8 &#956;M dCTP-<sup>32</sup>P and varying amounts of purified Pol &#946; protein (WT and R137Q). WT and R137Q DNA polymerization products were separated by denaturing gel electrophoresis and visualized with a phosphorimager. (<bold>B</bold>) DNA polymerization products were pulled down by Sepharose&#8211;avidin beads. After washing, the amount of radio-nucleotide incorporated into the products was determined by liquid scintillation counting. (<bold>C</bold>) Gel shift assay of DNA-binding affinity of R137Q and WT Pol &#946;. In this assay, Pol-GAP was labeled by <sup>32</sup>P as shown in figure. (<bold>D</bold>) ELISA-based isotherm adsorption assay of DNA-binding affinity of R137Q and WT Pol &#946;. The DNA substrate was the same as that used in (A). WT, filled squares; R137, filled circles.</p></caption><graphic xlink:href="gkp201f1"/></fig>
The polymerase activity assay utilized 50 mM Tris-HCl (pH 8.0), 10 mM MgCl2, 2 mM DTT, 20 mM NaCl, 10% glycerol, 0.1 microM biotin-labeled DNA substrate Pol-GAP (see Table 1 and Figure 1A for detail), 50 microM each dATP, dGTP and dTTP (Sigma), 8 microM 2 microCi [alpha-32P]-dCTP and 0-10 ng WT or R137Q Pol beta. Reactions were carried out at 37degreesC for 30 min. A portion of reaction product was taken out and incubated with avidin-Sepharose 4B beads, washed and quantified on liquid scintillation analyzer. The left portion of reaction product was then stopped by addition of equal volumes of gel loading buffer (90% formamide dye, 3 M EDTA, 0.02% bromophenol blue and 0.02% xylene cyanol), heated (5 min, 95degreesC), separated by 15% Polyacrylamide gel electrophoresis (PAGE) containing 8 M urea and visualized by autoradiography. Figure 1.The Pol beta polymorphism R137Q is defective in polymerase activity. (A) Top panel, schematic of the biotin-labeled 1-nt gapped DNA substrate (Pol-GAP); bottom panel, polymerase activity assay in which Pol-GAP was incubated with 50 muM each of dATP, dGTP, dTTP and 8 muM dCTP-32P and varying amounts of purified Pol beta protein (WT and R137Q). WT and R137Q DNA polymerization products were separated by denaturing gel electrophoresis and visualized with a phosphorimager. (B) DNA polymerization products were pulled down by Sepharose-avidin beads. After washing, the amount of radio-nucleotide incorporated into the products was determined by liquid scintillation counting. (C) Gel shift assay of DNA-binding affinity of R137Q and WT Pol beta. In this assay, Pol-GAP was labeled by 32P as shown in figure. (D) ELISA-based isotherm adsorption assay of DNA-binding affinity of R137Q and WT Pol beta. The DNA substrate was the same as that used in (A). WT, filled squares; R137, filled circles.
###end p 14
###begin p 15
###xml 70 71 67 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 276 278 271 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 474 475 466 467 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 676 677 668 669 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 783 785 772 774 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 808 809 797 798 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
The Pol beta polymorphism R137Q is defective in polymerase activity. (A) Top panel, schematic of the biotin-labeled 1-nt gapped DNA substrate (Pol-GAP); bottom panel, polymerase activity assay in which Pol-GAP was incubated with 50 muM each of dATP, dGTP, dTTP and 8 muM dCTP-32P and varying amounts of purified Pol beta protein (WT and R137Q). WT and R137Q DNA polymerization products were separated by denaturing gel electrophoresis and visualized with a phosphorimager. (B) DNA polymerization products were pulled down by Sepharose-avidin beads. After washing, the amount of radio-nucleotide incorporated into the products was determined by liquid scintillation counting. (C) Gel shift assay of DNA-binding affinity of R137Q and WT Pol beta. In this assay, Pol-GAP was labeled by 32P as shown in figure. (D) ELISA-based isotherm adsorption assay of DNA-binding affinity of R137Q and WT Pol beta. The DNA substrate was the same as that used in (A). WT, filled squares; R137, filled circles.
###end p 15
###begin title 16
DNA-binding assay
###end title 16
###begin p 17
###xml 368 369 362 363 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1033 1036 1008 1011 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">450</sub>
###xml 835 840 <span type="species:ncbi:10090">mouse</span>
###xml 888 892 <span type="species:ncbi:9925">goat</span>
###xml 898 903 <span type="species:ncbi:10090">mouse</span>
Gel shift and ELISA-based isothermal absorption assays were used to compare the DNA-binding affinity between WT and R137Q Pol beta. For gel shift assays, various concentrations of Pol beta protein (0.1-1000 nM) were incubated (15 min, room temperature) with 0.1 nM radio-labeled Pol-GAP substrate in a buffer containing 50 mM Tris-HCl (pH 8.0), 100 mM NaCl, 10 mM MgCl2, 10% glycerol and 0.1% NP-40. Samples were run on a 5% native polyacrylamide gel and visualized by autoradiography. For ELISA-based affinity assays, biotin-labeled Pol-GAP DNA substrate (1 pmol) was immobilized on a streptavidin-coated 96-well Enzyme-Linked ImmunoSorbent Assay (ELISA) plate and washed three times with binding buffer, followed by the addition of 0-1 microg WT or R137Q Pol beta and incubated (overnight, 4degreesC). Bound Pol beta was detected by mouse anti-Pol beta antibody (Genetex, GTX23181) and goat anti-mouse IgG/HRP (Genetex, GTX85313). Color was developed by adding tetramethyl benzidine (TMB) and stopped by addition of 1 N HCl. The OD450 was read on a microplate reader.
###end p 17
###begin title 18
dRP lyase assay
###end title 18
###begin p 19
###xml 91 93 88 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 185 187 175 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 465 466 446 447 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
The dRP lyase assay using purified Pol beta protein was performed as described previously (41). To prepare the dRP lyase substrate, the DNA substrate Pol beta-U was labeled with (gamma-32P)-ATP at the 5'-end on the U-containing oligonucleotide, followed by treatment with uracil-DNA glycosylase (UDG) and APE1. The incised AP-site-containing DNA was then incubated (20 min, 37degreesC) with Pol beta (0-10 ng) in a buffer containing 50 mM HEPES (pH 7.5), 10 mM MgCl2, 20 mM KCl and 2 mM DTT, stabilized by addition of 2 M sodium borohydride to a final concentration of 340 mM, followed by incubation on ice (30 min). Formamide-containing gel loading buffer was then added and reaction products were resolved on 15% polyacrylamide gels containing 8 M urea and visualized by autoradiography.
###end p 19
###begin title 20
Reconstituted base excision repair assay
###end title 20
###begin p 21
###xml 53 55 53 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 56 58 56 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 59 61 59 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 186 187 182 183 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 302 304 282 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 523 530 493 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table&#160;1</xref>
###xml 567 574 534 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table&#160;1</xref>
The BER assay was performed as described previously (22,42,43). Complete repair reactions were carried out in 20 microl of reaction buffer [40 mM HEPES-KOH (pH 7.8), 70 mM KCI, 7 mM MgCl2, 1 mM dithiothreitol, 0.5 mM EDTA, 2 mM ATP, 50 microM each of dATP, dTTP and dGTP, and 8 microM 2 microCi (alpha-32P)-dCTP]. For short-patch reconstitution with purified proteins, UDG (8 ng), APE1 (2 ng), Ligase IIIalpha (20 ng) and various amounts of Pol beta (0-5 ng), were mixed and incubated with the SP-BER substrate Pol beta-U (Table 1). For LP BER, Pol beta-F substrate (Table 1) was incubated with the mixture of APE1 (2 ng), Pol beta (0-5 ng), FEN1 (2 ng), and Ligase I (20 ng). Note that in the LP-BER substrate, radio-labeled dCTP can only be incorporated in the second position next to the damaged base. For cell extract reconstitution, SP- or LP-BER DNA substrate was incubated with the total cell extracts (0-5 microg). Reactions (30 min, 37degreesC) were then stopped by adding an equal volume of the gel loading buffer and visualized by autoradiography.
###end p 21
###begin title 22
Cell lines and culture
###end title 22
###begin p 23
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</italic>
###xml 7 15 7 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 22 30 19 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 30 33 24 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 101 103 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 267 275 261 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 275 278 266 269 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 286 294 277 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 294 297 282 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 35 40 <span type="species:ncbi:10090">mouse</span>
WT and pol beta null (pol beta-/-) mouse embryonic fibroblast (MEF) cells were described previously (15). Cells were grown in Dulbecco's; Modified Eagle Medium (DMEM) medium supplemented with 10% FBS and 100 units each of penicillin, streptomycin and hygromycin. The pol beta-/-/WT and pol beta-/-/R137Q stable cell lines were generated by using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. Selection was carried out using 100 microg/ml of G418.
###end p 23
###begin title 24
Preparation of cell extracts
###end title 24
###begin p 25
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 51 53 51 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 93 94 93 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 222 223 222 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 571 572 561 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
Cell extracts were made according to Biade et al. (43). Briefly, cells were cultured in 10 cm2 dishes, incubated overnight to reach a mid-exponential growth phase, washed three times with ice-cold PBS and resuspended at 106 cells/20 microl in buffer I [10 mM Tris-HCl (pH 7.8) and 200 mM KCl]. After the addition of an equal volume of Buffer II [10 mM Tris-HCl (pH 7.8), 200 mM KCl, 2 mM EDTA, 40% glycerol, 0.2% NP-40, 2 mM dithiothreitol, 0.5 mM PMSF and protease inhibitor cocktail (Roche)], the cell suspension was rocked (1 h, 4degreesC), centrifuged (10 min, 16 000g) and the supernatant recovered and stored (-80degreesC). Protein concentrations were determined by Bradford protein assay.
###end p 25
###begin title 26
Pull-down assay
###end title 26
###begin p 27
###xml 162 170 155 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 170 173 160 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 571 573 545 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 999 1001 960 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
To determine the interaction between R137Q and proteins in the BER complex, His-tagged Pol beta protein (20 microg) was mixed with cell extract prepared from the pol beta-/- MEF cell line (50 microg) in 150 microl binding buffer [50 mM Tris-HCl (pH 7.6), 75 mM KCl, 1 mM DTT, 10 mM imidazole], incubated (60 min, on ice) and 15 microl of pre-equilibrated nickel beads were added to the mixture which was once again incubated (1 h, on ice, with constant shaking). Beads were then washed five times with the binding buffer, suspended in SDS-PAGE sample buffer (50 microl) (31), boiled (5 min, 95degreesC) and the supernatant subjected to SDS-PAGE followed by western blotting with antibodies against APE1 (Genetex, GTX70132), FEN1 (Genetex, GTX70186), PCNA (Genetex, GTX70286), Ligase IIIalpha (Genetex, GTX70144), Ligase I (Genetex, GTX70142) and XRCC1 (Genetex, GTX70262). To confirm the interaction between Pol beta and PCNA, purified PCNA was immobilized on Sepharose 4B, as previously described (40); PCNA coated beads were then mixed with purified WT or R137Q Pol beta. After incubation (60 min, on ice) and washing with binding buffer, Sepharose 4B beads were boiled in SDS-PAGE sample buffer and the supernatant analyzed by western blotting with anti-Pol beta and PCNA antibodies.
###end p 27
###begin title 28
DNA damage assay
###end title 28
###begin p 29
###xml 47 49 47 49 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 438 441 438 441 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">450</sub>
DNA damage assay was carried out as described (44). Briefly, monolayer cells were treated (1 h) with MMS at different concentrations, collected and genomic DNA was extracted by using DNAzol reagent (Invitrogen). Extracted DNA was then coated onto ELISA plates and detected by AP-site specific reagent, Aldehyde-Reactive Probe (ARP) (Invitrogen), followed by detection with HRP-conjugated streptavidin and TMB. After stopping by 1N HCl, OD450 was measured on a microplate reader.
###end p 29
###begin title 30
MMS and MNU sensitivity assay
###end title 30
###begin p 31
###xml 345 346 327 328 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 261 267 <span type="species:ncbi:9913">bovine</span>
Sensitivity to MMS and MNU was determined by HeLa cell growth inhibition assay. HeLa cells were seeded (1500/well), incubated (overnight, 37degreesC). Treated (1 h, 37degreesC) with multiple dilutions of MMS, washed in a fresh medium (DMEM containing 10% fetal bovine serum) and incubated (72 h) under normal growth conditions (37degreesC, 5% CO2). The number of viable cells was determined by the CellTiter 96 AQueous one-solution cell proliferation assay (Promega). At least four replicas for each clone were averaged. Data are expressed as the percentage of growth relative to untreated controls.
###end p 31
###begin title 32
Cell apoptosis analysis
###end title 32
###begin p 33
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 198 199 198 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
The cell cycle distribution and apoptosis of stably complemented cell lines were analyzed by Fluorescence Activated Cell Sorting (FACS) analysis, as previously described (45). Harvested cells (10 cm2 dish) were fixed with pre-chilled 70% ethanol, stained with propidium iodide (PI; Sigma) and analyzed by flow cytometry at the City of Hope Flow Cytometry Core Facility.
###end p 33
###begin title 34
RESULTS
###end title 34
###begin title 35
The R137Q variant is defective in polymerase activity
###end title 35
###begin p 36
###xml 165 170 162 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 173 175 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 754 762 745 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in&#160;vitro</italic>
###xml 796 803 787 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table&#160;1</xref>
###xml 912 920 891 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure&#160;1</xref>
###xml 1041 1050 1020 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figures&#160;1</xref>
###xml 1059 1060 1038 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 1261 1270 1240 1249 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure&#160;2.</label>
###xml 1309 1310 1285 1286 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1436 1438 1409 1411 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1683 1685 1656 1658 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1735 1737 1708 1710 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1750 1751 1723 1724 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1783 1784 1756 1757 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1270 1845 1249 1818 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="37">dRP lyase activity assay of Pol &#946;. (<bold>A</bold>) Schematic representation of the reactions generating a 5&#8242;-dRP-group-containing DNA substrate. Treatment of Pol &#946;-U (with <sup>32</sup>P labeled at 3&#8242;end) with UDG generates an AP-containing DNA, which then was incised at the nucleotide 5&#8242; to the AP site by APE1, resulting the 5&#8242;-dRP-containing substrate (20&#8201;nt&#8201;+&#8201;dRP). Removal of the 5&#8242;-dRP residue by dRP lyase results in a 3&#8242;-<sup>32</sup>P labeled 20&#8201;nt DNA fragment. Asterisk represents <sup>32</sup>P labeling. (<bold>B</bold>) 5&#8242;-dRP lyase activity assay. (<bold>C</bold>) Quantification of the 5&#8242;-dRP lyase activities shown in (B).</p>
###xml 1270 1845 1249 1818 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="37">dRP lyase activity assay of Pol &#946;. (<bold>A</bold>) Schematic representation of the reactions generating a 5&#8242;-dRP-group-containing DNA substrate. Treatment of Pol &#946;-U (with <sup>32</sup>P labeled at 3&#8242;end) with UDG generates an AP-containing DNA, which then was incised at the nucleotide 5&#8242; to the AP site by APE1, resulting the 5&#8242;-dRP-containing substrate (20&#8201;nt&#8201;+&#8201;dRP). Removal of the 5&#8242;-dRP residue by dRP lyase results in a 3&#8242;-<sup>32</sup>P labeled 20&#8201;nt DNA fragment. Asterisk represents <sup>32</sup>P labeling. (<bold>B</bold>) 5&#8242;-dRP lyase activity assay. (<bold>C</bold>) Quantification of the 5&#8242;-dRP lyase activities shown in (B).</p></caption>
###xml 1845 1845 1818 1818 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp201f2"/>
###xml 1261 1845 1240 1818 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F2" position="float"><label>Figure&#160;2.</label><caption><p textid="37">dRP lyase activity assay of Pol &#946;. (<bold>A</bold>) Schematic representation of the reactions generating a 5&#8242;-dRP-group-containing DNA substrate. Treatment of Pol &#946;-U (with <sup>32</sup>P labeled at 3&#8242;end) with UDG generates an AP-containing DNA, which then was incised at the nucleotide 5&#8242; to the AP site by APE1, resulting the 5&#8242;-dRP-containing substrate (20&#8201;nt&#8201;+&#8201;dRP). Removal of the 5&#8242;-dRP residue by dRP lyase results in a 3&#8242;-<sup>32</sup>P labeled 20&#8201;nt DNA fragment. Asterisk represents <sup>32</sup>P labeling. (<bold>B</bold>) 5&#8242;-dRP lyase activity assay. (<bold>C</bold>) Quantification of the 5&#8242;-dRP lyase activities shown in (B).</p></caption><graphic xlink:href="gkp201f2"/></fig>
###xml 110 115 <span type="species:ncbi:9606">Human</span>
###xml 649 654 <span type="species:ncbi:9606">human</span>
The Pol beta polymorphism (rs12678588) encoding an Arg137 to Gln substitution was initially identified by the Human Genome Project and was confirmed by Mohrenweiser et al. (46). This polymorphism has been identified in Caucasians, Africans and Asians with rare occurrence frequency (National Center for Biotechnology Information database and reference 38). However, the extent of the impact of this polymorphism on disease development, especially carcinogenesis, has not been fully elucidated. To determine the effects of the R137Q Pol beta variant on biochemical activities and/or biological functions, we first expressed and purified WT and R137Q human Pol beta proteins, and then assayed the primer extension, dRP lyase and substrate-binding activity in vitro, using synthetic DNA substrates (Table 1). We found that the R137Q variant had approximately30% primer extension activity compared to the WT enzyme (Figure 1A and B). However, no differences were observed in the R137Q variant for the DNA-binding activity or dRP lyase activity (Figures 1C, D and 2). These results were consistent with the fact that R137Q occurred at the 31-kDa domain, the polymerase catalytic domain, while the 8-kDa domain was responsible for dRP lyase and DNA-binding activity. Figure 2.dRP lyase activity assay of Pol beta. (A) Schematic representation of the reactions generating a 5'-dRP-group-containing DNA substrate. Treatment of Pol beta-U (with 32P labeled at 3'end) with UDG generates an AP-containing DNA, which then was incised at the nucleotide 5' to the AP site by APE1, resulting the 5'-dRP-containing substrate (20 nt + dRP). Removal of the 5'-dRP residue by dRP lyase results in a 3'-32P labeled 20 nt DNA fragment. Asterisk represents 32P labeling. (B) 5'-dRP lyase activity assay. (C) Quantification of the 5'-dRP lyase activities shown in (B).
###end p 36
###begin p 37
###xml 39 40 36 37 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 166 168 160 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 413 415 407 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 465 467 459 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 480 481 474 475 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 513 514 507 508 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
dRP lyase activity assay of Pol beta. (A) Schematic representation of the reactions generating a 5'-dRP-group-containing DNA substrate. Treatment of Pol beta-U (with 32P labeled at 3'end) with UDG generates an AP-containing DNA, which then was incised at the nucleotide 5' to the AP site by APE1, resulting the 5'-dRP-containing substrate (20 nt + dRP). Removal of the 5'-dRP residue by dRP lyase results in a 3'-32P labeled 20 nt DNA fragment. Asterisk represents 32P labeling. (B) 5'-dRP lyase activity assay. (C) Quantification of the 5'-dRP lyase activities shown in (B).
###end p 37
###begin title 38
The R137Q variant has an impaired interaction with PCNA
###end title 38
###begin p 39
###xml 100 108 100 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 108 111 105 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 291 299 288 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure&#160;3</xref>
###xml 711 719 694 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure&#160;3</xref>
###xml 860 861 843 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
###xml 1225 1233 1202 1210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure&#160;3</xref>
###xml 1629 1637 1594 1602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure&#160;3</xref>
###xml 1641 1650 1606 1615 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure&#160;3.</label>
###xml 1717 1718 1679 1680 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1779 1787 1741 1746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 2123 2124 2075 2076 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 2465 2466 2411 2412 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1650 2872 1615 2809 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="40">The R137Q Pol &#946; variant has an impaired interaction with PCNA. (<bold>A</bold>) Ni-NTA pull-down was performed with the cell extracts from <italic>pol &#946;</italic> null MEFs and purified Pol &#946; or R137Q variant proteins (His-tagged). The interaction was detected by western blotting using antibodies against FEN1, APE1, PCNA, Ligase 1, Ligase III&#945; and XRCC1. A negative control with His-tagged GST was added to rule out the possibility that desirable proteins interact with His tag directly. (<bold>B</bold>) Pull-down assay using purified proteins. Purified PCNA was immobilized on Sepharose 4B beads, incubated with purified Pol &#946; (WT or R137Q), washed and beads were then boiled in SDS&#8211;PAGE sample buffer. Proteins were separated by SDS&#8211;PAGE and transferred onto PVDF film, followed by detection with anti-Pol &#946; and anti-PCNA antibodies. (<bold>C</bold>) Affinity comparison of PCNA with WT and R137Q Pol &#946; by ELISA. PCNA was coated onto ELISA plates, incubated with different concentrations of purified WT or R137Q Pol &#946;, washed and bound protein was detected by mouse anti-Pol &#946; antibody and goat anti-mouse IgG/HRP. Color was developed by adding TMB. The color reaction was stopped by adding 1&#8201;N HCl. Optical density was read on microplate reader.</p>
###xml 1650 2872 1615 2809 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="40">The R137Q Pol &#946; variant has an impaired interaction with PCNA. (<bold>A</bold>) Ni-NTA pull-down was performed with the cell extracts from <italic>pol &#946;</italic> null MEFs and purified Pol &#946; or R137Q variant proteins (His-tagged). The interaction was detected by western blotting using antibodies against FEN1, APE1, PCNA, Ligase 1, Ligase III&#945; and XRCC1. A negative control with His-tagged GST was added to rule out the possibility that desirable proteins interact with His tag directly. (<bold>B</bold>) Pull-down assay using purified proteins. Purified PCNA was immobilized on Sepharose 4B beads, incubated with purified Pol &#946; (WT or R137Q), washed and beads were then boiled in SDS&#8211;PAGE sample buffer. Proteins were separated by SDS&#8211;PAGE and transferred onto PVDF film, followed by detection with anti-Pol &#946; and anti-PCNA antibodies. (<bold>C</bold>) Affinity comparison of PCNA with WT and R137Q Pol &#946; by ELISA. PCNA was coated onto ELISA plates, incubated with different concentrations of purified WT or R137Q Pol &#946;, washed and bound protein was detected by mouse anti-Pol &#946; antibody and goat anti-mouse IgG/HRP. Color was developed by adding TMB. The color reaction was stopped by adding 1&#8201;N HCl. Optical density was read on microplate reader.</p></caption>
###xml 2872 2872 2809 2809 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp201f3"/>
###xml 1641 2872 1606 2809 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F3" position="float"><label>Figure&#160;3.</label><caption><p textid="40">The R137Q Pol &#946; variant has an impaired interaction with PCNA. (<bold>A</bold>) Ni-NTA pull-down was performed with the cell extracts from <italic>pol &#946;</italic> null MEFs and purified Pol &#946; or R137Q variant proteins (His-tagged). The interaction was detected by western blotting using antibodies against FEN1, APE1, PCNA, Ligase 1, Ligase III&#945; and XRCC1. A negative control with His-tagged GST was added to rule out the possibility that desirable proteins interact with His tag directly. (<bold>B</bold>) Pull-down assay using purified proteins. Purified PCNA was immobilized on Sepharose 4B beads, incubated with purified Pol &#946; (WT or R137Q), washed and beads were then boiled in SDS&#8211;PAGE sample buffer. Proteins were separated by SDS&#8211;PAGE and transferred onto PVDF film, followed by detection with anti-Pol &#946; and anti-PCNA antibodies. (<bold>C</bold>) Affinity comparison of PCNA with WT and R137Q Pol &#946; by ELISA. PCNA was coated onto ELISA plates, incubated with different concentrations of purified WT or R137Q Pol &#946;, washed and bound protein was detected by mouse anti-Pol &#946; antibody and goat anti-mouse IgG/HRP. Color was developed by adding TMB. The color reaction was stopped by adding 1&#8201;N HCl. Optical density was read on microplate reader.</p></caption><graphic xlink:href="gkp201f3"/></fig>
###xml 2683 2688 <span type="species:ncbi:10090">mouse</span>
###xml 2716 2720 <span type="species:ncbi:9925">goat</span>
###xml 2726 2731 <span type="species:ncbi:10090">mouse</span>
We then investigated the effects of R137Q substitution on protein-protein interactions. Extracts of pol beta-/- MEF were incubated with purified WT or R137Q proteins (His-tagged) prior to immunoprecipitation of proteins involved in the BER pathway and detection by corresponding antibodies (Figure 3). Six proteins (APE1, FEN1, PCNA, XRCC1, Ligase I and Ligase IIIalpha) that interact with Pol beta and are involved in either the SP- or LP-BER pathways were investigated. The amount of APE1, FEN1, XRCC1, Ligase 1 or Ligase IIIalpha that co-pulled down with R137Q was similar to that with the WT enzyme. However, there was a dramatic decrease in levels of R137Q-bound PCNA compared with WT Pol beta-bound PCNA (Figure 3A, panel 2). To rule out the possibility that the His tag itself is responsible for the observed binding, we included His-tagged glutathione S-transferase (GST) as a control. In this case, none of the tested proteins binds to His-tag or GST. To further confirm this observation, we immobilized purified PCNA on Sepharose 4B beads and incubated them with purified WT or R137Q Pol beta. Western blot of Sepharose bead-bound proteins showed that WT Pol beta but not R137Q was efficiently pulled down by PCNA (Figure 3B), suggesting that the Arg137 to Gln substitution impaired the interaction between Pol beta and PCNA. To quantitatively evaluate the impact of the R137Q substitution on the Pol beta/PCNA interaction, we determined the relative amount of WT Pol beta or R137Q-bound PCNA by ELISA. Our data suggested that levels of WT Pol beta-bound PCNA were 1.5- to 4-fold higher than those of R137Q-bound PCNA (Figure 3C). Figure 3.The R137Q Pol beta variant has an impaired interaction with PCNA. (A) Ni-NTA pull-down was performed with the cell extracts from pol beta null MEFs and purified Pol beta or R137Q variant proteins (His-tagged). The interaction was detected by western blotting using antibodies against FEN1, APE1, PCNA, Ligase 1, Ligase IIIalpha and XRCC1. A negative control with His-tagged GST was added to rule out the possibility that desirable proteins interact with His tag directly. (B) Pull-down assay using purified proteins. Purified PCNA was immobilized on Sepharose 4B beads, incubated with purified Pol beta (WT or R137Q), washed and beads were then boiled in SDS-PAGE sample buffer. Proteins were separated by SDS-PAGE and transferred onto PVDF film, followed by detection with anti-Pol beta and anti-PCNA antibodies. (C) Affinity comparison of PCNA with WT and R137Q Pol beta by ELISA. PCNA was coated onto ELISA plates, incubated with different concentrations of purified WT or R137Q Pol beta, washed and bound protein was detected by mouse anti-Pol beta antibody and goat anti-mouse IgG/HRP. Color was developed by adding TMB. The color reaction was stopped by adding 1 N HCl. Optical density was read on microplate reader.
###end p 39
###begin p 40
###xml 67 68 64 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 129 137 126 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 473 474 460 461 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 815 816 796 797 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1033 1038 <span type="species:ncbi:10090">mouse</span>
###xml 1066 1070 <span type="species:ncbi:9925">goat</span>
###xml 1076 1081 <span type="species:ncbi:10090">mouse</span>
The R137Q Pol beta variant has an impaired interaction with PCNA. (A) Ni-NTA pull-down was performed with the cell extracts from pol beta null MEFs and purified Pol beta or R137Q variant proteins (His-tagged). The interaction was detected by western blotting using antibodies against FEN1, APE1, PCNA, Ligase 1, Ligase IIIalpha and XRCC1. A negative control with His-tagged GST was added to rule out the possibility that desirable proteins interact with His tag directly. (B) Pull-down assay using purified proteins. Purified PCNA was immobilized on Sepharose 4B beads, incubated with purified Pol beta (WT or R137Q), washed and beads were then boiled in SDS-PAGE sample buffer. Proteins were separated by SDS-PAGE and transferred onto PVDF film, followed by detection with anti-Pol beta and anti-PCNA antibodies. (C) Affinity comparison of PCNA with WT and R137Q Pol beta by ELISA. PCNA was coated onto ELISA plates, incubated with different concentrations of purified WT or R137Q Pol beta, washed and bound protein was detected by mouse anti-Pol beta antibody and goat anti-mouse IgG/HRP. Color was developed by adding TMB. The color reaction was stopped by adding 1 N HCl. Optical density was read on microplate reader.
###end p 40
###begin title 41
The R137Q variant has lower BER efficiency
###end title 41
###begin p 42
###xml 335 342 329 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table&#160;1</xref>
###xml 494 496 488 490 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 605 613 599 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure&#160;4</xref>
###xml 845 853 836 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure&#160;4</xref>
###xml 997 1005 988 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure&#160;1</xref>
###xml 1032 1034 1023 1025 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1133 1141 1124 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure&#160;4</xref>
###xml 1271 1279 1259 1264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 1367 1375 1349 1357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure&#160;5</xref>
###xml 1675 1683 1645 1653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure&#160;5</xref>
###xml 1693 1702 1663 1672 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure&#160;4.</label>
###xml 1747 1748 1717 1718 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1810 1811 1777 1778 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1702 2205 1672 2167 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="43">R137Q significantly reduces BER efficiency. (<bold>A</bold>) SP-BER reconstitution with purified WT and R137Q Pol &#946;. (<bold>B</bold>) LP-BER reconstitution with purified WT and R137Q. The top part of each panel shows the schematic structures of the corresponding DNA substrates. The middle shows PAGE-separated products and the bottom the relative percentage of repaired product obtained with the indicated amounts of Pol &#946;. Values represent mean&#8201;&#177;&#8201;SD of three independent assays. WT, filled squares; R137, filled circle.</p>
###xml 1702 2205 1672 2167 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="43">R137Q significantly reduces BER efficiency. (<bold>A</bold>) SP-BER reconstitution with purified WT and R137Q Pol &#946;. (<bold>B</bold>) LP-BER reconstitution with purified WT and R137Q. The top part of each panel shows the schematic structures of the corresponding DNA substrates. The middle shows PAGE-separated products and the bottom the relative percentage of repaired product obtained with the indicated amounts of Pol &#946;. Values represent mean&#8201;&#177;&#8201;SD of three independent assays. WT, filled squares; R137, filled circle.</p></caption>
###xml 2205 2205 2167 2167 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp201f4"/>
###xml 1693 2205 1663 2167 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F4" position="float"><label>Figure&#160;4.</label><caption><p textid="43">R137Q significantly reduces BER efficiency. (<bold>A</bold>) SP-BER reconstitution with purified WT and R137Q Pol &#946;. (<bold>B</bold>) LP-BER reconstitution with purified WT and R137Q. The top part of each panel shows the schematic structures of the corresponding DNA substrates. The middle shows PAGE-separated products and the bottom the relative percentage of repaired product obtained with the indicated amounts of Pol &#946;. Values represent mean&#8201;&#177;&#8201;SD of three independent assays. WT, filled squares; R137, filled circle.</p></caption><graphic xlink:href="gkp201f4"/></fig>
###xml 2205 2214 2167 2176 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure&#160;5.</label>
###xml 2303 2304 2262 2263 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 2431 2439 2384 2389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 2439 2442 2389 2392 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2532 2533 2475 2476 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 2577 2578 2520 2521 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 2943 2951 2884 2889 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 2951 2954 2889 2892 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2977 2985 2915 2920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 2985 2988 2920 2923 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 3006 3014 2941 2946 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 3014 3017 2946 2949 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2214 3038 2176 2970 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="44">Polymorphic Pol &#946; R137Q is defective in BER reconstitution using whole cell extract. (<bold>A</bold>) Western blotting shows the establishment of cell lines that express the Pol &#946; WT protein or polymorphic Pol &#946; R137Q in <italic>pol &#946;</italic><sup>&#8722;/&#8722;</sup> MEF cells. Amount of Pol &#946; protein was detected in 100&#8201;&#181;g of total cell extract. (<bold>B</bold>) SP-BER reconstitution with WT and R137Q. (<bold>C</bold>) LP-BER reconstitution with WT and R137Q. The top part of each panel shows the schematic structure of the corresponding DNA substrates. The middle shows PAGE-separated products and the bottom the relative percentage of repaired product at different enzyme concentrations, as indicated. Values represent mean&#8201;&#177;&#8201;SD of three independent assays. WT, filled squares; <italic>pol &#946;</italic><sup>&#8722;/&#8722;</sup>/WT, filled triangles; <italic>pol &#946;</italic><sup>&#8722;/&#8722;</sup>, filled circles; <italic>pol &#946;</italic><sup>&#8722;/&#8722;</sup>/R137Q, open squares.</p>
###xml 2214 3038 2176 2970 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="44">Polymorphic Pol &#946; R137Q is defective in BER reconstitution using whole cell extract. (<bold>A</bold>) Western blotting shows the establishment of cell lines that express the Pol &#946; WT protein or polymorphic Pol &#946; R137Q in <italic>pol &#946;</italic><sup>&#8722;/&#8722;</sup> MEF cells. Amount of Pol &#946; protein was detected in 100&#8201;&#181;g of total cell extract. (<bold>B</bold>) SP-BER reconstitution with WT and R137Q. (<bold>C</bold>) LP-BER reconstitution with WT and R137Q. The top part of each panel shows the schematic structure of the corresponding DNA substrates. The middle shows PAGE-separated products and the bottom the relative percentage of repaired product at different enzyme concentrations, as indicated. Values represent mean&#8201;&#177;&#8201;SD of three independent assays. WT, filled squares; <italic>pol &#946;</italic><sup>&#8722;/&#8722;</sup>/WT, filled triangles; <italic>pol &#946;</italic><sup>&#8722;/&#8722;</sup>, filled circles; <italic>pol &#946;</italic><sup>&#8722;/&#8722;</sup>/R137Q, open squares.</p></caption>
###xml 3038 3038 2970 2970 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp201f5"/>
###xml 2205 3038 2167 2970 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F5" position="float"><label>Figure&#160;5.</label><caption><p textid="44">Polymorphic Pol &#946; R137Q is defective in BER reconstitution using whole cell extract. (<bold>A</bold>) Western blotting shows the establishment of cell lines that express the Pol &#946; WT protein or polymorphic Pol &#946; R137Q in <italic>pol &#946;</italic><sup>&#8722;/&#8722;</sup> MEF cells. Amount of Pol &#946; protein was detected in 100&#8201;&#181;g of total cell extract. (<bold>B</bold>) SP-BER reconstitution with WT and R137Q. (<bold>C</bold>) LP-BER reconstitution with WT and R137Q. The top part of each panel shows the schematic structure of the corresponding DNA substrates. The middle shows PAGE-separated products and the bottom the relative percentage of repaired product at different enzyme concentrations, as indicated. Values represent mean&#8201;&#177;&#8201;SD of three independent assays. WT, filled squares; <italic>pol &#946;</italic><sup>&#8722;/&#8722;</sup>/WT, filled triangles; <italic>pol &#946;</italic><sup>&#8722;/&#8722;</sup>, filled circles; <italic>pol &#946;</italic><sup>&#8722;/&#8722;</sup>/R137Q, open squares.</p></caption><graphic xlink:href="gkp201f5"/></fig>
###xml 1227 1232 <span type="species:ncbi:9606">human</span>
###xml 1258 1263 <span type="species:ncbi:10090">mouse</span>
The impaired biochemical functions of the R137Q variant suggested that R137Q likely affected BER function. To test this hypothesis, SP- and LP-BER were assayed using purified proteins. Uracil-containing substrate (Pol beta-U) and tetrahydrofuran-containing substrate (Pol beta-F) were used for SP- and LP-BER substrates, respectively (Table 1). Cleavage of the uracil or Tetrahydrofuran (THF) lesion by the concerted action of UDG and APE1 resulted in a nicked DNA duplex, and incorporation of 32P-dCTP and other deoxynucleotides produced 20-30 nt non-ligated intermediates visible to the phosphorimager (Figure 4A and B). Further processing of this intermediate structure generated a fully repaired product of 40 nt. We observed that the uracil or THF lesions were efficiently repaired in the presence of WT Pol beta but not the R137Q variant (Figure 4A and B). The reduced repair efficiency by R137Q was likely due to its low-polymerase activity. Consistent with the polymerase activity assays (Figure 1A), only a small amount of 32P-dCTP was incorporated into the DNA substrate by R137Q in reconstituted SP- and LP-BER reactions (Figure 4A and B). To validate that the R137Q variant lead to low-BER efficiency, we expressed human WT and R137Q Pol beta in mouse MEF of pol beta knockout genetic background. Cells expressing similar level of Pol beta were selected (Figure 5A). Nuclear extracts (NEs) from these cell lines were prepared and their BER efficiency assayed. We found that WT NE efficiently repaired the uracil or THF lesion, resulting in a 40 nt band, whereas the repair efficiency by R137Q NE was only approximately10 and 20% for SP- and LP-BER, respectively (Figure 5B and C). Figure 4.R137Q significantly reduces BER efficiency. (A) SP-BER reconstitution with purified WT and R137Q Pol beta. (B) LP-BER reconstitution with purified WT and R137Q. The top part of each panel shows the schematic structures of the corresponding DNA substrates. The middle shows PAGE-separated products and the bottom the relative percentage of repaired product obtained with the indicated amounts of Pol beta. Values represent mean +/- SD of three independent assays. WT, filled squares; R137, filled circle.Figure 5.Polymorphic Pol beta R137Q is defective in BER reconstitution using whole cell extract. (A) Western blotting shows the establishment of cell lines that express the Pol beta WT protein or polymorphic Pol beta R137Q in pol beta-/- MEF cells. Amount of Pol beta protein was detected in 100 microg of total cell extract. (B) SP-BER reconstitution with WT and R137Q. (C) LP-BER reconstitution with WT and R137Q. The top part of each panel shows the schematic structure of the corresponding DNA substrates. The middle shows PAGE-separated products and the bottom the relative percentage of repaired product at different enzyme concentrations, as indicated. Values represent mean +/- SD of three independent assays. WT, filled squares; pol beta-/-/WT, filled triangles; pol beta-/-, filled circles; pol beta-/-/R137Q, open squares.
###end p 42
###begin p 43
###xml 45 46 45 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 108 109 105 106 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
R137Q significantly reduces BER efficiency. (A) SP-BER reconstitution with purified WT and R137Q Pol beta. (B) LP-BER reconstitution with purified WT and R137Q. The top part of each panel shows the schematic structures of the corresponding DNA substrates. The middle shows PAGE-separated products and the bottom the relative percentage of repaired product obtained with the indicated amounts of Pol beta. Values represent mean +/- SD of three independent assays. WT, filled squares; R137, filled circle.
###end p 43
###begin p 44
###xml 89 90 86 87 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 217 225 208 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 225 228 213 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 318 319 299 300 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 363 364 344 345 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 729 737 708 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 737 740 713 716 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 763 771 739 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 771 774 744 747 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 792 800 765 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 800 803 770 773 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
Polymorphic Pol beta R137Q is defective in BER reconstitution using whole cell extract. (A) Western blotting shows the establishment of cell lines that express the Pol beta WT protein or polymorphic Pol beta R137Q in pol beta-/- MEF cells. Amount of Pol beta protein was detected in 100 microg of total cell extract. (B) SP-BER reconstitution with WT and R137Q. (C) LP-BER reconstitution with WT and R137Q. The top part of each panel shows the schematic structure of the corresponding DNA substrates. The middle shows PAGE-separated products and the bottom the relative percentage of repaired product at different enzyme concentrations, as indicated. Values represent mean +/- SD of three independent assays. WT, filled squares; pol beta-/-/WT, filled triangles; pol beta-/-, filled circles; pol beta-/-/R137Q, open squares.
###end p 44
###begin title 45
###xml 35 43 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
Expression of the R137Q variant in pol beta knockout cells failed to restore DNA damage resistance capacity
###end title 45
###begin p 46
###xml 205 213 202 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 224 232 218 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 232 235 223 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 241 249 232 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 249 252 237 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 306 314 291 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 314 317 296 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 324 327 306 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol</italic>
###xml 327 330 309 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 396 398 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 427 435 409 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 517 525 494 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure&#160;6</xref>
###xml 572 580 549 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure&#160;6</xref>
###xml 743 751 717 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 765 770 736 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R137Q</italic>
###xml 955 963 926 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure&#160;6</xref>
###xml 1020 1028 991 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 1028 1031 996 999 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1068 1076 1036 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 1076 1079 1041 1044 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1164 1172 1129 1134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 1172 1175 1134 1137 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1221 1229 1183 1188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 1229 1232 1188 1191 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1252 1260 1211 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure&#160;6</xref>
###xml 1270 1279 1229 1238 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure&#160;6.</label>
###xml 1351 1352 1310 1311 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1524 1525 1483 1484 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1583 1591 1542 1547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 1591 1594 1547 1550 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1601 1609 1557 1562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pol &#946;</italic>
###xml 1609 1612 1562 1565 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1917 1925 1867 1872 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 1925 1928 1872 1875 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1930 1938 1877 1882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 1938 1941 1882 1885 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1949 1957 1893 1898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 1957 1960 1898 1901 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2006 2007 1947 1948 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 2018 2019 1959 1960 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 2205 2213 2144 2149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 2213 2216 2149 2152 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2239 2247 2175 2180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 2247 2250 2180 2183 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2268 2276 2201 2206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 2276 2279 2206 2209 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1279 2300 1238 2230 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="47">Cells harboring polymorphism R137Q are sensitive to DNA damage stress. (<bold>A</bold>) Abasic-specific DNA damage assay. Cells were treated with MMS. The amount of damaged DNA lesions was then detected by ARP reagent (see Experimental Procedures section). (<bold>B</bold>) Effect of MMS on induction of apoptosis in complemented <italic>pol &#946;</italic><sup>&#8722;/&#8722;</sup> MEFs. <italic>Pol &#946;</italic><sup>&#8722;/&#8722;</sup> MEFs complemented with WT or the R137Q variant of Pol &#946; were treated (1&#8201;h) with 2&#8201;mM MMS. Adherent and floating cells were harvested after 24&#8201;h and analyzed by flow cytometry. The percentage of the apoptotic cells indicated. The MMS-induced increase of apoptotic cells is shown in the bottom bar. WT, <italic>pol &#946;</italic><sup>&#8722;/&#8722;</sup>, <italic>pol &#946;</italic><sup>&#8722;/&#8722;</sup>/WT and <italic>pol &#946;</italic><sup>&#8722;/&#8722;</sup>/R137Q MEF cells were treated (1&#8201;h) with MMS (<bold>C</bold>) and MNU (<bold>D</bold>) at the indicated concentrations. Cellular sensitivity was determined by growth inhibition experiments. Data represents mean&#8201;&#177;&#8201;SD of four independent experiments. WT, filled squares; <italic>pol &#946;</italic><sup>&#8722;/&#8722;</sup>/WT, filled triangles; <italic>pol &#946;</italic><sup>&#8722;/&#8722;</sup>, filled circles; <italic>pol &#946;</italic><sup>&#8722;/&#8722;</sup>/R137Q, open squares.</p>
###xml 1279 2300 1238 2230 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="47">Cells harboring polymorphism R137Q are sensitive to DNA damage stress. (<bold>A</bold>) Abasic-specific DNA damage assay. Cells were treated with MMS. The amount of damaged DNA lesions was then detected by ARP reagent (see Experimental Procedures section). (<bold>B</bold>) Effect of MMS on induction of apoptosis in complemented <italic>pol &#946;</italic><sup>&#8722;/&#8722;</sup> MEFs. <italic>Pol &#946;</italic><sup>&#8722;/&#8722;</sup> MEFs complemented with WT or the R137Q variant of Pol &#946; were treated (1&#8201;h) with 2&#8201;mM MMS. Adherent and floating cells were harvested after 24&#8201;h and analyzed by flow cytometry. The percentage of the apoptotic cells indicated. The MMS-induced increase of apoptotic cells is shown in the bottom bar. WT, <italic>pol &#946;</italic><sup>&#8722;/&#8722;</sup>, <italic>pol &#946;</italic><sup>&#8722;/&#8722;</sup>/WT and <italic>pol &#946;</italic><sup>&#8722;/&#8722;</sup>/R137Q MEF cells were treated (1&#8201;h) with MMS (<bold>C</bold>) and MNU (<bold>D</bold>) at the indicated concentrations. Cellular sensitivity was determined by growth inhibition experiments. Data represents mean&#8201;&#177;&#8201;SD of four independent experiments. WT, filled squares; <italic>pol &#946;</italic><sup>&#8722;/&#8722;</sup>/WT, filled triangles; <italic>pol &#946;</italic><sup>&#8722;/&#8722;</sup>, filled circles; <italic>pol &#946;</italic><sup>&#8722;/&#8722;</sup>/R137Q, open squares.</p></caption>
###xml 2300 2300 2230 2230 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp201f6"/>
###xml 1270 2300 1229 2230 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F6" position="float"><label>Figure&#160;6.</label><caption><p textid="47">Cells harboring polymorphism R137Q are sensitive to DNA damage stress. (<bold>A</bold>) Abasic-specific DNA damage assay. Cells were treated with MMS. The amount of damaged DNA lesions was then detected by ARP reagent (see Experimental Procedures section). (<bold>B</bold>) Effect of MMS on induction of apoptosis in complemented <italic>pol &#946;</italic><sup>&#8722;/&#8722;</sup> MEFs. <italic>Pol &#946;</italic><sup>&#8722;/&#8722;</sup> MEFs complemented with WT or the R137Q variant of Pol &#946; were treated (1&#8201;h) with 2&#8201;mM MMS. Adherent and floating cells were harvested after 24&#8201;h and analyzed by flow cytometry. The percentage of the apoptotic cells indicated. The MMS-induced increase of apoptotic cells is shown in the bottom bar. WT, <italic>pol &#946;</italic><sup>&#8722;/&#8722;</sup>, <italic>pol &#946;</italic><sup>&#8722;/&#8722;</sup>/WT and <italic>pol &#946;</italic><sup>&#8722;/&#8722;</sup>/R137Q MEF cells were treated (1&#8201;h) with MMS (<bold>C</bold>) and MNU (<bold>D</bold>) at the indicated concentrations. Cellular sensitivity was determined by growth inhibition experiments. Data represents mean&#8201;&#177;&#8201;SD of four independent experiments. WT, filled squares; <italic>pol &#946;</italic><sup>&#8722;/&#8722;</sup>/WT, filled triangles; <italic>pol &#946;</italic><sup>&#8722;/&#8722;</sup>, filled circles; <italic>pol &#946;</italic><sup>&#8722;/&#8722;</sup>/R137Q, open squares.</p></caption><graphic xlink:href="gkp201f6"/></fig>
###xml 264 269 <span type="species:ncbi:9606">human</span>
###xml 592 597 <span type="species:ncbi:9606">human</span>
###xml 649 654 <span type="species:ncbi:10090">mouse</span>
Our observation that R137Q Pol beta caused defective BER led us to propose that cells expressing the R137Q variant would be sensitive to DNA base damaging agents. To test this hypothesis, MEF cells of WT, pol beta knockout (pol beta-/-) and pol beta-/- expressing human WT or R137Q Pol beta (designated as pol beta-/-/WT or pol-/-/R137Q) were treated with MMS. Consistent with a previous report (15), we found that deletion of pol beta caused cells to accumulate MMS-induced DNA damage at MMS concentrations >/=1 mM (Figure 6A) and to become sensitive to the MMS and MNU (Figure 6B-D). While human WT Pol beta fully complemented the function of its mouse homolog, R137Q only partially complemented it. FACS data showed that apoptotic cells of pol beta knock out or R137Q genetic background were considerably higher than the WT background. Additionally, there was a 5-fold increase in MMS-induced apoptotic R137Q cells compared with WT (3.1% versus 0.6%) (Figure 6B). MMS consistently had a stronger inhibitory effect on pol beta-/--R137Q cell growth relative to WT or pol beta-/-/WT cells. Following MMS or MNU treatment, the ratio of MMS or MNU treated/untreated pol beta-/--R137Q cells was <10%, whereas that for WT or pol beta-/--WT cells was >90% (Figure 6C and D). Figure 6.Cells harboring polymorphism R137Q are sensitive to DNA damage stress. (A) Abasic-specific DNA damage assay. Cells were treated with MMS. The amount of damaged DNA lesions was then detected by ARP reagent (see Experimental Procedures section). (B) Effect of MMS on induction of apoptosis in complemented pol beta-/- MEFs. Pol beta-/- MEFs complemented with WT or the R137Q variant of Pol beta were treated (1 h) with 2 mM MMS. Adherent and floating cells were harvested after 24 h and analyzed by flow cytometry. The percentage of the apoptotic cells indicated. The MMS-induced increase of apoptotic cells is shown in the bottom bar. WT, pol beta-/-, pol beta-/-/WT and pol beta-/-/R137Q MEF cells were treated (1 h) with MMS (C) and MNU (D) at the indicated concentrations. Cellular sensitivity was determined by growth inhibition experiments. Data represents mean +/- SD of four independent experiments. WT, filled squares; pol beta-/-/WT, filled triangles; pol beta-/-, filled circles; pol beta-/-/R137Q, open squares.
###end p 46
###begin p 47
###xml 72 73 72 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 245 246 245 246 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 304 312 304 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 312 315 309 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 322 330 319 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pol &#946;</italic>
###xml 330 333 324 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 638 646 629 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 646 649 634 637 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 651 659 639 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 659 662 644 647 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 670 678 655 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 678 681 660 663 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 727 728 709 710 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 739 740 721 722 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 926 934 906 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 934 937 911 914 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 960 968 937 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 968 971 942 945 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 989 997 963 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 997 1000 968 971 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
Cells harboring polymorphism R137Q are sensitive to DNA damage stress. (A) Abasic-specific DNA damage assay. Cells were treated with MMS. The amount of damaged DNA lesions was then detected by ARP reagent (see Experimental Procedures section). (B) Effect of MMS on induction of apoptosis in complemented pol beta-/- MEFs. Pol beta-/- MEFs complemented with WT or the R137Q variant of Pol beta were treated (1 h) with 2 mM MMS. Adherent and floating cells were harvested after 24 h and analyzed by flow cytometry. The percentage of the apoptotic cells indicated. The MMS-induced increase of apoptotic cells is shown in the bottom bar. WT, pol beta-/-, pol beta-/-/WT and pol beta-/-/R137Q MEF cells were treated (1 h) with MMS (C) and MNU (D) at the indicated concentrations. Cellular sensitivity was determined by growth inhibition experiments. Data represents mean +/- SD of four independent experiments. WT, filled squares; pol beta-/-/WT, filled triangles; pol beta-/-, filled circles; pol beta-/-/R137Q, open squares.
###end p 47
###begin title 48
DISCUSSION
###end title 48
###begin p 49
###xml 153 155 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 197 205 191 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 314 316 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 317 319 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 320 322 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
###xml 848 856 830 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in&#160;vitro</italic>
###xml 861 868 843 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in&#160;vivo</italic>
###xml 112 117 <span type="species:ncbi:9606">human</span>
###xml 295 300 <span type="species:ncbi:10090">mouse</span>
###xml 366 374 <span type="species:ncbi:9606">patients</span>
Pol beta plays a key role in the DNA BER pathway and is critical for normal cell function. Approximately 30% of human cancers contain abnormal Pol beta (47). Cancer-associated somatic mutations of pol beta usually induce genomic instability and lead to cellular transformation when expressed in mouse fibroblasts (31,48,49). Unlike somatic mutations found in cancer patients, polymorphisms exist in normal populations and are hypothesized to be liable for the onset of cancer. Given the importance of Pol beta in maintaining DNA integrity, we were interested in providing mechanistic insights associated with cancer development of a newly identified polymorphism of Pol beta, R137Q. Here, we show that the R137Q variant decreases Pol beta polymerase activity and impairs its interaction with PCNA and the overall capacity to repair DNA base damage in vitro and in vivo. Our study suggests that an individual with R137Q polymorphism may be sensitive to endogenous and exogenous DNA damaging agents, and consequently be susceptible to cancer development.
###end p 49
###begin p 50
###xml 158 160 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 476 484 455 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure&#160;1</xref>
The amino acid residue Arg137 can be very important for Pol beta function. According to the crystal structure, R137 maps to the catalytic domain of Pol beta (20). At this site, R137 is required to form hydrogen bonds with other adjacent amino acid residuals. The substitution of R137Q might disrupt the formation of hydrogen bonds and thus impair polymerase activity. Consistent with this speculation, R137Q has approximately30% of the DNA polymerase activity of WT pol beta (Figure 1A and B).
###end p 50
###begin p 51
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 715 717 706 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
Arg137 also serves as a protein posttranslational modification site. Recent research by Hottiger and coworkers (39) found that Arg137 of Pol beta was methylated by protein arginine transferase 1 (PRMT1). Contrary to Hottiger's work suggesting Pol beta methylation at R137 did not affect Pol beta polymerase activity, our data indicated that R137Q substitution greatly reduced polymerase activity. Disparities in the two studies may have been due to differences in the properties between glutamine and a methylated arginine. Methylation of arginine increases molecular size and hydrophobicity but keeps the positive charge intact, while the arginine to glutamine substitution abolishes the positive arginine charge (50).
###end p 51
###begin p 52
###xml 70 78 70 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure&#160;3</xref>
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">51</xref>
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
###xml 416 418 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 524 526 511 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 607 609 591 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 677 679 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 1081 1083 1053 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 1274 1276 1240 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 1429 1431 1392 1394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
Our work shows that Arg137 is a regulatory site for PCNA interaction (Figure 3). PCNA, through its direct interaction with a broad range of other cellular proteins, plays essential roles in many aspects of DNA metabolism in mammalian cells (51). PCNA was reported to enhance the LP-BER by stimulating FEN1 activity (52). Based on the polymerase used, the LP-BER can be categorized into Pol beta-independent pathway (13), where Pol delta/ϵ are involved, and Pol beta-dependent pathway, where Pol beta is the only polymerase (14). PCNA was once thought only to be involved in the Pol beta-independent LP-BER (13). However, recently Pol beta has been shown to interact with PCNA (26), implying that PCNA may be also involved in Pol beta-dependent BER. In the current study, the evaluation of the specific physiological significance of impairment of the interaction between PCNA and R137Q Pol beta was complicated by the polymerase activity defect. However, we could imagine that PCNA may regulate BER by facilitating Pol beta's recruitment to DNA/protein complexes formed during BER (39). It is worth to point out that R137 is also a methylation site of Pol beta. A very recent study showed that Pol beta can be methylated by protein arginine methyltransferase 1 at R137 site (39). Consistent with our result, methylation at R137 also blocks the interaction between Pol beta and PCNA. Moreover, according to Hottiger and coworkers (39), methylation at R137 site of Pol beta regulates BER efficiency. However, cells carrying the R137Q polymorphism cannot be methylated at the R137 site anymore, resulting in a loss of the BER regulatory mechanism. In living cells, the R137Q polymorphism could exert its effects at different levels by impairing enzyme activity, reducing protein interaction and blocking protein posttranslational modifications, exemplifying how a subtle change in polymorphism can have significant consequences to cells.
###end p 52
###begin p 53
###xml 463 465 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B53">53</xref>
###xml 430 435 <span type="species:ncbi:9606">human</span>
###xml 933 938 <span type="species:ncbi:9606">human</span>
Because DNA continuously undergoes alterations, either spontaneously or induced by endogenous and exogenous factors, highly efficient DNA repair systems are critical to remove damaged DNA lesions and to maintain genome integrity. Although the genetic effect of an individual polymorphism is generally subtle, combinations of functionally relevant polymorphisms may additively or synergistically contribute to an increased risk of human diseases, such as cancers (53). In this study, we demonstrated that one single nucleotide substitution can have profound consequences on protein function and overall phenotype of organisms. The effects of the polymorphism on proteins are multiple and occur in several segregable aspects. The effect on each aspect seems subtle, but the overall consequence can be obvious and dramatic. In this case, the Pol beta R137Q polymorphism may significantly contribute to the initiation and development of human cancers through its potentially synergistic effects of impaired polymerase activity, interaction with PCNA and necessary methylation modification.
###end p 53
###begin title 54
FUNDING
###end title 54
###begin p 55
###xml 0 29 0 29 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">National Institutes of Health</funding-source>
###xml 31 43 31 43 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R01 CA085344</award-id>
National Institutes of Health (R01 CA085344 to B.S.). Funding for open access charge: National Institutes of Health/NCI.
###end p 55
###begin p 56
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 56
###begin title 57
ACKNOWLEDGEMENTS
###end title 57
###begin p 58
###xml 103 111 103 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol &#946;</italic>
###xml 111 114 108 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
We thank Samuel Wilson of National Institute of Environmental Health Sciences (NIEH) for providing the pol beta-/- MEF cells used in this study and Keely Walker and Silvia da Costa for editorial assistance.
###end p 58
###begin title 59
REFERENCES
###end title 59
###begin article-title 60
###xml 64 69 <span type="species:ncbi:9606">human</span>
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
###end article-title 60
###begin article-title 61
Genome maintenance mechanisms for preventing cancer
###end article-title 61
###begin article-title 62
Base excision DNA repair
###end article-title 62
###begin article-title 63
Base-excision repair of oxidative DNA damage
###end article-title 63
###begin article-title 64
Instability and decay of the primary structure of DNA
###end article-title 64
###begin article-title 65
Quality control by DNA repair
###end article-title 65
###begin article-title 66
Highly sensitive apurinic/apyrimidinic site assay can detect spontaneous and chemically induced depurination under physiological conditions
###end article-title 66
###begin article-title 67
Molecular and biological roles of Ape1 protein in mammalian base excision repair
###end article-title 67
###begin article-title 68
###xml 46 51 <span type="species:ncbi:9606">human</span>
Long patch base excision repair with purified human proteins. DNA ligase I as patch size mediator for DNA polymerases delta and epsilon
###end article-title 68
###begin article-title 69
Two pathways for base excision repair in mammalian cells
###end article-title 69
###begin article-title 70
Mammalian abasic site base excision repair. Identification of the reaction sequence and rate-determining steps
###end article-title 70
###begin article-title 71
Excision of deoxyribose phosphate residues by DNA polymerase beta during DNA repair
###end article-title 71
###begin article-title 72
The mechanism of switching among multiple BER pathways
###end article-title 72
###begin article-title 73
###xml 33 38 <span type="species:ncbi:9606">human</span>
Second pathway for completion of human DNA base excision-repair: reconstitution with purified proteins and requirement for DNase IV (FEN1)
###end article-title 73
###begin article-title 74
Requirement of mammalian DNA polymerase-beta in base-excision repair
###end article-title 74
###begin article-title 75
###xml 54 59 <span type="species:ncbi:9606">human</span>
Characterization of the DNA polymerase requirement of human base excision repair
###end article-title 75
###begin article-title 76
Protection against methylation-induced cytotoxicity by DNA polymerase beta-dependent long patch base excision repair
###end article-title 76
###begin article-title 77
DNA polymerase beta is the major dRP lyase involved in repair of oxidative base lesions in DNA by mammalian cell extracts
###end article-title 77
###begin article-title 78
Activities and mechanism of DNA polymerase beta
###end article-title 78
###begin article-title 79
Structure and mechanism of DNA polymerase Beta
###end article-title 79
###begin article-title 80
Domain specific interaction in the XRCC1-DNA polymerase beta complex
###end article-title 80
###begin article-title 81
###xml 57 62 <span type="species:ncbi:9606">human</span>
Reconstitution of DNA base excision-repair with purified human proteins: interaction between DNA polymerase beta and the XRCC1 protein
###end article-title 81
###begin article-title 82
Mapping of the interaction interface of DNA polymerase beta with XRCC1
###end article-title 82
###begin article-title 83
XRCC1-DNA polymerase beta interaction is required for efficient base excision repair
###end article-title 83
###begin article-title 84
XRCC1 and DNA polymerase beta interaction contributes to cellular alkylating-agent resistance and single-strand break repair
###end article-title 84
###begin article-title 85
Direct interaction between mammalian DNA polymerase beta and proliferating cell nuclear antigen
###end article-title 85
###begin article-title 86
HMGB1 is a cofactor in mammalian base excision repair
###end article-title 86
###begin article-title 87
FEN1 stimulation of DNA polymerase beta mediates an excision step in mammalian long patch base excision repair
###end article-title 87
###begin article-title 88
Mammalian DNA beta-polymerase in base excision repair of alkylation damage
###end article-title 88
###begin article-title 89
Variant forms of DNA polymerase beta in primary lung carcinomas
###end article-title 89
###begin article-title 90
The E295K DNA polymerase beta gastric cancer-associated variant interferes with base excision repair and induces cellular transformation
###end article-title 90
###begin article-title 91
The mutator form of polymerase beta with amino acid substitution at tyrosine 265 in the hinge region displays an increase in both base substitution and frame shift errors
###end article-title 91
###begin article-title 92
Hinge residue Ile260 of DNA polymerase beta is important for enzyme activity and fidelity
###end article-title 92
###begin article-title 93
Polymorphisms in DNA repair genes and associations with cancer risk
###end article-title 93
###begin article-title 94
###xml 21 26 <span type="species:ncbi:9606">human</span>
Polymorphisms in the human DNA polymerase beta gene
###end article-title 94
###begin article-title 95
The Leu22Pro tumor-associated variant of DNA polymerase beta is dRP lyase deficient
###end article-title 95
###begin article-title 96
###xml 76 81 <span type="species:ncbi:9606">human</span>
Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function
###end article-title 96
###begin article-title 97
###xml 21 24 <span type="species:ncbi:10116">rat</span>
Crystal structure of rat DNA polymerase beta: evidence for a common polymerase mechanism
###end article-title 97
###begin article-title 98
Methylation of DNA polymerase beta by protein arginine methyltransferase 1 regulates its binding to proliferating cell nuclear antigen
###end article-title 98
###begin article-title 99
Comprehensive mapping of the C-terminus of flap endonuclease-1 reveals distinct interaction sites for five proteins that represent different DNA replication and repair pathways
###end article-title 99
###begin article-title 100
###xml 46 51 <span type="species:ncbi:9606">human</span>
A mechanism for the exclusion of low-fidelity human Y-family DNA polymerases from base excision repair
###end article-title 100
###begin article-title 101
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human DNA polymerase beta initiates DNA synthesis during long-patch repair of reduced AP sites in DNA
###end article-title 101
###begin article-title 102
Impairment of proliferating cell nuclear antigen-dependent apurinic/apyrimidinic site repair on linear DNA
###end article-title 102
###begin article-title 103
A novel, sensitive, and specific assay for abasic sites, the most commonly produced DNA lesion
###end article-title 103
###begin article-title 104
Arginine methylation regulates DNA polymerase beta
###end article-title 104
###begin article-title 105
###xml 91 97 <span type="species:ncbi:9606">humans</span>
Identification of 127 amino acid substitution variants in screening 37 DNA repair genes in humans
###end article-title 105
###begin article-title 106
Is there a link between DNA polymerase beta and cancer?
###end article-title 106
###begin article-title 107
###xml 66 71 <span type="species:ncbi:10090">mouse</span>
Expression of DNA polymerase {beta} cancer-associated variants in mouse cells results in cellular transformation
###end article-title 107
###begin article-title 108
A DNA polymerase beta mutant from colon cancer cells induces mutations
###end article-title 108
###begin article-title 109
Protein arginine methyltransferases: evolution and assessment of their pharmacological and therapeutic potential
###end article-title 109
###begin article-title 110
Proliferating cell nuclear antigen (PCNA): a dancer with many partners
###end article-title 110
###begin article-title 111
Role of DNA polymerase beta in the excision step of long patch mammalian base excision repair
###end article-title 111
###begin article-title 112
SNP-SNP interactions in breast cancer susceptibility
###end article-title 112

